Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alvarez

Showing results (551-560 of 565) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|June 23, 1999
Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationshipsC L Strickland, P C Weber, W T Windsor, et al.
Journal of the American Geriatrics Society|September 12, 2025
Malnutrition Mortality Among Older Adults by County and Race and/or Ethnicity in the United States, 2000-2019Juliana Teruel Camargo, Jessica Otero Machuca, Amanda S Hinerman, et al.
Journal of Cardiac Failure|December 12, 2025
Impact of Controlled Hypothermic Preservation On Early Outcomes in Heart Transplant RecipientsNichanan Osataphan, Nitish K Dhingra, Laura Hastenteufel, et al.
Journal of Medicinal Chemistry|November 21, 1998
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agentF G Njoroge, A G Taveras, J Kelly, et al.
Journal of the National Cancer Institute|April 4, 2026
Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019Jinani Jayasekera, Somy Hooshmand, Paula D Strassle, et al.
BMC Medicine|March 18, 2026
Cause-specific years of life lost attributable to non-optimal body mass index by county, sex, race, and ethnicity in the USA, 2000-2019: a systematic analysis of health disparities, Farah Mouhanna, Ethan Kahn, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
The Review of Scientific Instruments|November 2, 2010
Images of the laser entrance hole from the static x-ray imager at NIFM B Schneider, O S Jones, N B Meezan, et al.
Science (New York, N.Y.)|June 26, 2007
Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoesRobert M Waterhouse, Evgenia V Kriventseva, Stephan Meister, et al.
ACS Omega|November 24, 2025
Evaluation of the Activity of 4‑Quinolones against Multi-Life Stages of <i>Plasmodium</i> sppYasmin Annunciato, Everton M da Silva, Jéssica E Araújo, et al.
Pageof 57

Showing results (551-560 of 565) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|June 23, 1999
Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationshipsC L Strickland, P C Weber, W T Windsor, et al.
Journal of the American Geriatrics Society|September 12, 2025
Malnutrition Mortality Among Older Adults by County and Race and/or Ethnicity in the United States, 2000-2019Juliana Teruel Camargo, Jessica Otero Machuca, Amanda S Hinerman, et al.
Journal of Cardiac Failure|December 12, 2025
Impact of Controlled Hypothermic Preservation On Early Outcomes in Heart Transplant RecipientsNichanan Osataphan, Nitish K Dhingra, Laura Hastenteufel, et al.
Journal of Medicinal Chemistry|November 21, 1998
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agentF G Njoroge, A G Taveras, J Kelly, et al.
Journal of the National Cancer Institute|April 4, 2026
Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019Jinani Jayasekera, Somy Hooshmand, Paula D Strassle, et al.
BMC Medicine|March 18, 2026
Cause-specific years of life lost attributable to non-optimal body mass index by county, sex, race, and ethnicity in the USA, 2000-2019: a systematic analysis of health disparities, Farah Mouhanna, Ethan Kahn, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
The Review of Scientific Instruments|November 2, 2010
Images of the laser entrance hole from the static x-ray imager at NIFM B Schneider, O S Jones, N B Meezan, et al.
Science (New York, N.Y.)|June 26, 2007
Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoesRobert M Waterhouse, Evgenia V Kriventseva, Stephan Meister, et al.
ACS Omega|November 24, 2025
Evaluation of the Activity of 4‑Quinolones against Multi-Life Stages of <i>Plasmodium</i> sppYasmin Annunciato, Everton M da Silva, Jéssica E Araújo, et al.
Pageof 57